M F12
Pill imprint M F12 has been identified as Felodipine extended release 5 mg.
Felodipine is used in the treatment of high blood pressure; raynaud's syndrome; angina pectoris prophylaxis and belongs to the drug class calcium channel blocking agents. Risk cannot be ruled out during pregnancy.
Felodipine 5 mg is not subject to the Controlled Substances Act.
See also related documents.
Felodipine extended release Images
- Imprint:
-
M
F12 - Strength:
- 5 mg
- Color:
- Yellow
- Size:
- 11.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- butylated hydroxyanisole
butylated hydroxytoluene
silicon dioxide
hypromellose
microcrystalline cellulose
polydextrose
polyethylene glycol
povidone
sodium stearyl fumarate
titanium dioxide
D&C Yellow No. 10
FD&C Blue No. 2
FD&C Yellow No. 6
- Drug Class:
- Calcium channel blocking agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-5012
| NDC Code | Manufacturer / Repackager |
|---|---|
| 51079-0467 | UDL Laboratories Inc |
Note: Inactive ingredients may vary.
Advertisement
More Felodipine Extended Release resources
- Felodipine (Wolters Kluwer)
- felodipine (Cerner Multum)
- felodipine (Micromedex) - Includes Dosage Information
- Felodipine (AHFS DI)
- Felodipine (FDA)
- Felodipine (Wolters Kluwer)
Search Again
